U.S. Global Investors, Inc. (GROW) is a San Antonio-based boutique registered investment adviser founded in 1968. It manages actively managed mutual funds and thematic exchange-traded funds focused on gold and precious metals, natural resources, airlines, and luxury goods, alongside a government ultra-short bond fund. Because of its small size and thin trading, traditional sell-side firms provide almost no formal price targets.
MarketBeat reports no consensus price target for the stock, and TipRanks lists a single reiterated target of $2.50 from February 2026, below the current price. Weiss Ratings downgraded the name to Hold in September 2026. With no reliable multi-analyst consensus available, the $3.00 objective used here comes from public technical and valuation discussion. It represents a round-number psychological level that coincides with the roughly $2.89 to $3.23 zone cited in recent technical commentary.
With shares recently changing hands near $2.60, a move to $3.00 would require an advance of approximately 15% — a substantial move for a micro-cap that trades modest daily volume. The stock's 52-week range spans about $2.23 to $3.65, so $3.00 is well below the prior high. The company ended its most recent reported quarter with average assets under management (AUM) of roughly $1.6 billion, operating revenue of about $2.8 million, and net income near $2.7 million. Its market capitalization is only about $31 million to $33 million, while its balance sheet carries essentially no debt and a cash position in the low-to-mid $20 million range. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Several balance-sheet and capital-allocation features stand out. The company has no long-term debt and holds substantial cash relative to its market value, which cushions operations and funds its shareholder-return program. It pays a recurring monthly dividend (yielding roughly 3.5%) and has reduced its share count by about 15% over five years through buybacks, supporting per-share metrics. Demand for its gold, precious-metals, and natural-resources funds could lift AUM and management fees if commodity and inflation themes regain momentum.
The clearest headwinds are structural. Revenue has declined markedly from prior years as fee-based income follows volatile AUM, and operating and free cash flow have been thin or negative in recent periods. The stock's limited liquidity — average volume in the low tens of thousands of shares — makes price moves erratic and widens bid-ask spreads. A meaningful decline in commodity sentiment, continued fee compression, or a loss of fund assets would weigh on results. With essentially no sell-side support, the shares also lack the institutional sponsorship that can anchor valuations.
Published technical analysis identifies near-term support around $2.58, with additional support near $2.52 and $2.29 and the 52-week low near $2.23. On the upside, short-term resistance sits near $2.82, followed by mid-term and longer-term resistance in the $3.33 to $3.36 zone, just under the 52-week high of $3.65. The 200-day moving average has hovered near $2.65 to $2.72. The $3.00 objective therefore lies between the first resistance band and the more durable resistance zone in the low-$3.30s.
Because the $3.00 figure is a technical and valuation objective rather than a formal analyst target, it carries no defined research horizon. Investors should watch quarterly AUM and revenue trends, dividend declarations, share-buyback activity, and any filings or announcements affecting fund flows. Broader drivers such as gold and commodity prices, interest-rate expectations, and sector rotation into or out of precious-metals and natural-resources funds are also directly relevant to fee income and sentiment. From what I see, these elements will likely determine whether the level is tested.
Whether U.S. Global Investors (GROW) can reach $3.00 is an open question. The target is not an analyst consensus — there is effectively none — but a publicly discussed technical and psychological level roughly 15% above the recent price. The strongest supports are a clean balance sheet, ample cash, a monthly dividend, and buybacks, while the biggest obstacles are declining revenue, thin cash flow, poor liquidity, and absent institutional coverage. A sustained rise in AUM and commodity-related fund demand would be the most direct path higher; persistent fee erosion or outflows would argue against it. Investors should monitor AUM, dividend and buyback activity, and precious-metals sentiment rather than expect a defined analyst roadmap.
In my own research process I have found Tickeron's AI Daily Buy/Sell Signals useful for tracking names like this one. The tool uses artificial intelligence to monitor thousands of stocks and ETFs and generate Buy, Sell, or Hold signals based on changing market conditions and technical behavior. For a thin, low-liquidity name like GROW, it can help identify shifts in trend more efficiently than manual review alone. I find it complements traditional analysis when evaluating potential moves toward levels such as $3.00.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
GROW may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 27 of 35 cases where GROW's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 77%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where GROW's RSI Oscillator exited the oversold zone, 20 of 33 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 61%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 36 of 65 cases where GROW's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 55%.
Following a +5.69% 3-day Advance, the price is estimated to grow further. Considering data from situations where GROW advanced for three days, in 145 of 238 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GROW as a result. In 46 of 103 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 45%.
The Moving Average Convergence Divergence Histogram (MACD) for GROW turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 25 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 53%.
The 50-day moving average for GROW moved below the 200-day moving average on November 05, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GROW declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 64%.
The Aroon Indicator for GROW entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating fairly steady price growth. GROW’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 72 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.681) is normal, around the industry mean (2.412). P/E Ratio (10.417) is within average values for comparable stocks, (-2.386). Projected Growth (PEG Ratio) (0.010) is also within normal values, averaging (1.319). Dividend Yield (0.012) settles around the average of (0.270) among similar stocks. P/S Ratio (3.675) is also within normal values, averaging (15.694).
The Tickeron SMR rating for this company is 80 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 95 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GROW’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of mutual fund management services
Industry InvestmentManagers